Early-life microbiota diversification facilitates enterocyte proliferation

Microbial communities heavily influence metabolic profiles in the small intestine. During early-life, acquisition of diverse bacterial communities may promote epithelial maturation by increasing nutrient availability.
Early-life microbiota diversification facilitates enterocyte proliferation

The adult gastrointestinal tract is colonized by trillions of bacteria that influence cellular homeostasis through microbial metabolism of dietary and hepatic compounds. The microbiota ecosystem and associated metabolic networks are gradually established in the first years of life (2-3 years) beginning at birth. In healthy term infants, lactic-acid producing bacteria typically colonize the gut shortly after or during delivery and gradually increase in abundance with limited diversity throughout infancy. Delivery at earlier gestational ages (pre-term) is associated with expedited microbiota diversification and altered metabolic profiles in the gut. Evidence from germ-free mouse models has shown that microbial acquisition in the gut facilitates tissue growth and organization of the crypt-villus architecture associated with a mature intestinal tract. However, it remains unclear if distinct patterns of term and pre-term microbiome maturation confer functional changes in the developing small intestine.

Two neonatal intensive care unit physicians, Dr. Oleksandr Kudin and Dr. Josef Neu had access to fecal samples from term and pre-term patients and shared our interest in elucidating host response to neonatal microbiota. Dr. Kudin joined our research group as part of his research fellowship, and together we optimized organoid cultures for in vitro screening of microbial metabolites from patient fecal samples. Simultaneously, other publications demonstrated that lactate (derived from lactic acid producing bacteria in the term gut or from ingested milk) induces enterocyte proliferation, while structural proteins from bacteria (lipopolysaccharide, flagellin) activate toll-like receptor signaling and inflammatory responses. Given this evidence, we expected pre-term microbial communities to induce an inflammatory response while term microbial metabolites would facilitate epithelial maturation.

We first characterized microbial and metabolic composition in term and pre-term cohorts. As expected, term samples harbored microbial communities characterized primarily by lactic-acid producing bacteria (LAB). In contrast, the pre-term microbiome was more diverse and lacking prominent LAB species. The pre-term cohort exhibited a significantly higher metabolic capacity, notably including significant increases in secondary bile acids. These biotransformed bile acids have been shown to increase proliferation and epithelial regeneration following chemical-induced injury. Mapping metabolomics profiles to microbial KEGG pathways showed a significant increase in amino acid and vitamin biosynthetic pathways with a concomitant increase in overall metabolite concentrations.

To examine how these metabolites functionally affect the intestinal epithelium, we cultured small intestinal organoids with term and pre-term fecal metabolites. These organoids form “mini-guts” derived from intestinal stem cells which recapitulate epithelial morphology and cellular heterogeneity. Surprisingly, when cultured in the presence of pre-term fecal metabolites, we observed increased proliferation (fig. 1) and stem cell activation relative to term fecal metabolites without activation of inflammatory signaling pathways.

Figure 1: Ki67 immunofluorescence visualizing proliferation in small intestinal organoids cultured with term and pre-term stool supernatant.

Organoid models are an increasingly common and powerful tool for defining host-microbe interactions intrinsically linked to the biology of the intestinal epithelium. Recently, human organoids have been used to identify the functional effects of individual microbial metabolites and characterize mutational profiles after exposure to bacterial genotoxins. Our study demonstrates the capability to induce functional changes associated with entire microbial ecosystems in vitro using host fecal material. This approach may help clarify complex metabolic interactions between host and microbes in intestinal diseases such as colon cancer.

For more details, please refer to our paper. 

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Subscribe to the Topic

Life Sciences > Biological Sciences > Microbiology

Related Collections

With collections, you can get published faster and increase your visibility.

Microbiome dynamics in human diseases

The ‘human microbiome’ comprises the complex and diverse, microbial ecosystems that colonize different organs and tissues of the human bodies. The human microbiota consists of bacteria, archaea, viruses as well as eukaryotes (e.g. fungi and protozoa), which significantly impact the physiology, homeostasis and overall health of the human body. Since the microbiome is a complex and variable microbial community that responds to multiple factors, our current understanding of the microbiota dynamics and impact on disease development remains incomplete. BMC Microbiology announces the launch of the collection “Microbiome dynamics in human diseases“. We invite submissions of manuscripts on research articles and methods addressing the complex role of the human microbiome, especially in the context of human diseases and biological dysfunctions. By acknowledging that ‘human microbiome research’ is rapidly evolving and fundamentally changing the way we study and treat human diseases, the overall goal of the collection is to enhance our knowledge on microbiome diversity and functions, microbiome-host interactions, and the role of microbiomes in health and disease.

Publishing Model: Open Access

Deadline: Mar 29, 2024

Bacterial defense systems

Microbial evolution is driven by a dynamic interaction between bacteria and viruses (bacteriophages). Bacteria and archaea are frequently threated by bacteriophages and plasmids, also known as ‘mobile genetic elements’ (MGEs). To avoid cell death or genomic invasion, bacteria have developed several sophisticated defense strategies, like preventing cell entry (e.g. via receptor masking or variation) and infection (e.g. altruistic suicide and/or dormancy of infected cells to protect the clonal population), or activating cellular immunity comprising both innate mechanisms (e.g. restriction-modification systems) and adaptive mechanisms (e.g. the CRISPR-Cas systems). Conversely, bacteriophages have evolved strategies to evade or counteract many of these defense systems, e.g. anti-CRISPR and antirestriction proteins. Bacterial defense systems are therefore under constant selective pressure by bacteriophage attack, and they rapidly evolve to combat phage infection and parasitism. By acknowledging that research on bacterial defense mechanisms, as well as their potential applications, is rapidly evolving and fundamentally changing the way we understand microbial ecology and evolution, and possibly treat human diseases, BMC Microbiology welcome submissions to a collection on ‘Bacterial defense systems’. The overall goal of the collection is to explore the diverse strategies employed by bacteria to combat challenges such as phage attacks, antimicrobial agents, environmental stresses, and interactions with other microorganisms.

Publishing Model: Open Access

Deadline: May 31, 2024